“I also have no doubt that the interim analysis of our mild/moderate study will be impressive and primary endpoint will be met. Just a matter of time now.”

There is no interim analysis for the mild/moderate study. If CYDY can speed up enrollment, there’s a chance when get the initial data read out from the completed mild/moderate trial in June.

The interim analysis is for the severe study only and takes place when the data of 50 patients is available.The severe trial is enrolling very slowly and I don’t think there’s a timeframe on when they intentionally analysis of that data will take place.